Indocyanine Green For Injection

Indocyanine green (lCG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm and emits near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, enters the intestine through the biliary tract, and is finally excreted with feces.

This injectable indocyanine green has passed double consistency evaluations, ensuring high purity, low impurity content, and optimized storage conditions, providing stable and reliable diagnosis and treatment options to the medical community.

Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.

Advantages: Clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, fluorescent staining helps identify and treat membranes precisely, reducing complications.

Indications: Evaluation of liver reserve function. Liver tumor image development, liver segment identification, complicated biliary tract development, and bile leakage observation.

Advantages: ICG is an optimal method for evaluating liver reserve function due to its rapidity and safety. It helps identify liver structure clearly, improving surgical accuracy.

Indications: Accurate localization of tumors, image development of the lymphatic system, and assessment of blood supply.

Research and development focus on high-end medical devices (fluorescence imaging), contrast agent drugs (ICG, targeted agents), and core components (fluorescence CMOS modules, endoscopes), providing a full-chain solution. These products are utilized in more than 500 large hospitals.

Focusing on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD). The mission is to lead in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.